GREGORY JAMES MERTZ
Affiliation: University of New Mexico
- Placebo-controlled, double-blind trial of intravenous ribavirin for the treatment of hantavirus cardiopulmonary syndrome in North AmericaGregory J Mertz
Internal Medicine, University of New Mexico, Albuquerque, New Mexico 87131 0001, USA
Clin Infect Dis 39:1307-13. 2004..BACKGROUND. Ribavirin is active in vitro against hantaviruses, but the findings of an open trial of the use of intravenous ribavirin for the treatment of hantavirus cardiopulmonary syndrome (HCPS) were inconclusive...
- Diagnosis and treatment of new world hantavirus infectionsGregory J Mertz
Department of Internal Medicine, University of New Mexico, Albuquerque, New Mexico 87131 0001, USA
Curr Opin Infect Dis 19:437-42. 2006..The purpose of this review is to summarize the current knowledge regarding the diagnosis and treatment of indigenous new world hantavirus infections...
- Tularemic meningitis in the United StatesDiedre M Hofinger
Medicine Service, New Mexico VA Health Care System, 1501 San Pedro Dr SE, Albuquerque, NM 87108, USA
Arch Neurol 66:523-7. 2009..Tularemia is a zoonotic disease caused by Francisella tularensis. Tularemia presents with various clinical illnesses, but meningitis is rare...